Quarterly report pursuant to Section 13 or 15(d)

Schedule of Share Option Activity (Details)

v3.22.1
Schedule of Share Option Activity (Details) - $ / shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-Based Payment Arrangement [Abstract]    
Number of Options, Beginning Balance 2,320,097 756,383
Weighted average exercise price, Beginning Balance $ 4.19 $ 1.82
Weighted average remaining contractual term, Beginning Balance 7 years 4 months 24 days 8 years 8 months 12 days
Number of Options, Granted 725,301 1,229,590
Weighted average exercise price, Granted $ 1.01 $ 4.61
Number of Options, Additional options grant StemoniX holders   292,995
Weighted average exercise price, Additional options grant StemoniX holders   $ 4.61
Number of Options, assumed in Merger   55,840
Weighted average exercise price, Options assumed in Merger   $ 45.95
Number of Options, Exercised (5,174) (29,916)
Weighted average exercise price, Exercised $ 0.96 $ 1.24
Number of Options, Forfeited (255,766) (29,349)
Weighted average exercise price, Forfeited $ 4.22 $ 2.00
Number of Options, Expired (17,842) (7,000)
Weighted average exercise price, Expired $ 57.24 $ 1.39
Number of Options, Ending Balance 2,766,616 2,268,543
Weighted average exercise price, Ending Balance $ 3.01 $ 4.79
Weighted average remaining contractual term, Ending Balance 8 years 8 months 12 days 8 years 1 month 6 days
Number of Options, Exercisable 1,011,626  
Weighted average exercise price, Exercisable $ 3.72  
Weighted average remaining contractual term, Exercisable 7 years 7 months 6 days